|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 24/04/14 | PERNOD RICARD : looks for more bolt-on deals after U.S. buy | RE |
| 22/04/14 | Allergan : Activist investors see Ackman-Valeant deal as a model to follow | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Greg Hughes
CEO | Chief Executive Officer | - | 30/09/2023 |
Gina Rossi
DFI | Director of Finance/CFO | 54 | 31/03/2017 |
John Rosair
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 31/12/2014 | |
Haruhisa Inada
BRD | Director/Board Member | - | 29/04/2014 |
Shingo Torii
BRD | Director/Board Member | 73 | 30/04/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.36% | -1.99% | -14.67% | -30.35% | 234B | ||
| +0.39% | +0.60% | -43.37% | -55.43% | 40.73B | ||
| +0.09% | +0.11% | -43.60% | -53.29% | 20.55B | ||
| +0.39% | -1.74% | -46.46% | -67.28% | 15.87B | ||
| +0.07% | +2.00% | +4.34% | +37.40% | 10.35B | ||
| +0.89% | +0.87% | -45.49% | -70.88% | 8.64B | ||
| +1.93% | +0.75% | +8.37% | -46.73% | 8.2B | ||
| +1.79% | +3.65% | -40.63% | -64.95% | 6.69B | ||
| +3.03% | -1.38% | -30.71% | -51.87% | 5.32B | ||
| Average | +0.91% | +0.27% | -28.03% | -44.82% | 38.91B | |
| Weighted average by Cap. | -0.02% | -0.88% | -21.55% | -36.66% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















